A global angel investment group was created to leverage cross-pacific business opportunities by investing in early stage life science and healthcare companies, with an Asia connection. The firm invests in companies that are interested in performing development work in China, or commercializing their products in Asia; the firm makes use of relationships with Asia-based life science service providers to guide portfolio companies through the development process , and also assists companies with the Chinese regulatory process. The firm is pre-venture capital and can contribute business, scientific and regional expertise to companies to improve probability for success.
The firm will consider opportunities across the life science space, and is primarily focused on diagnostics and devices but also invests in therapeutics and life science tools. The firm generally invests in companies with products with strong animal data, and which are addressing a significant health problem in China (such as cancer, cardiovascular and metabolic diseases, infectious diseases, and also CNS disorders in some circumstances). Companies which have already attained approval in a market outside China may be of interest.
The firm invests in early stage deals. The firm only invests in companies that are interested in performing development work in China, or commercializing their products in China; the firm makes use of relationships with China-based life science service providers to guide portfolio companies through the development process and obtain matching government funds in China, and also assists companies with the Chinese regulatory process.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
This interactive workshop, organized and led by McDermott Will & Emery, will provide wisdom to early-stage CEOs and management on the latest trends in term sheets, with a focus on founder and management equity opportunities. The workshop will cover common issues of concern to entrepreneurs (valuation/dilution, liquidation preference, board makeup, protective provisions, anti-dilution). Experts from the legal, investment and entrepreneurial community will discuss the interplay of financing milestones in the term sheet discussion.
Startups that need access to incubators, laboratory space, and medical and research equipment have many options today. This workshop will map out how to determine the best opportunities for you and best practices to manage the process of evaluating lab space and procuring equipment. Topics discussed are the current laboratory and startup incubator space business models, equipment choices, and other auxiliary offerings like consulting and introduction to partners. How does a startup determine the best lab model and equipment for your current needs? Understand how to find and locate lab space and then ask the right questions to meet your current and future needs. The main topics to explore are inexperienced realtors with the cookie-cutter preconfigured lab space versus experienced customized midlevel and high-end build-out and the used versus new equipment. The workshop will explain what and where the pivot points are for shelling out the dollars for something new that will enhance and speed up product development and when to save money and go with the used, tried, and true. This workshop will empower you to navigate and make better choices and ask the right questions when choosing your laboratory and equipment providers.
Once you are ready to embark on your fundraising campaign, how do you know whom to target? What investors are the best fit for you, how do different investors invest and partner, and how do you get in touch with them? Identifying investors, learning about the differences between investor types, accessing a database to provide you with key information to filter your best-fit investors, and finally, using a CRM to manage your fundraise are critical to an efficient and successful fundraise.
Next Phase Newsletter 